Emergent Biosolutions Inc (NYSE: EBS) established initial surge of 36.60% at $12.84, as the Stock market unbolted on Thursday, before settling in for the price of $9.4 at the close. Taking a more long-term approach, EBS posted a 52-week range of $4.02-$12.73.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 750.72%. This publicly-traded company’s shares outstanding now amounts to $52.70 million, simultaneously with a float of $51.25 million. The organization now has a market capitalization sitting at $685.03 million. At the time of writing, stock’s 50-day Moving Average stood at $8.89, while the 200-day Moving Average is $7.40.
Emergent Biosolutions Inc (EBS) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Emergent Biosolutions Inc industry. Emergent Biosolutions Inc’s current insider ownership accounts for 3.94%, in contrast to 74.52% institutional ownership. According to the most recent insider trade that took place on Oct 07 ’25, this organization’s EVP, Quality & Ethics, and CPL sold 30,608 shares at the rate of 10.00, making the entire transaction reach 306,080 in total value, affecting insider ownership by 144,319.
Emergent Biosolutions Inc (EBS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.98 per share during the current fiscal year.
Emergent Biosolutions Inc’s EPS increase for this current 12-month fiscal period is 750.72% and is forecasted to reach 1.75 in the upcoming year.
Emergent Biosolutions Inc (NYSE: EBS) Trading Performance Indicators
Let’s observe the current performance indicators for Emergent Biosolutions Inc (EBS). It’s Quick Ratio in the last reported quarter now stands at 3.15. Alongside those numbers, its PE Ratio stands at $9.89, and its Beta score is 2.04. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.87. Similarly, its price to free cash flow for trailing twelve months is now 489.31.
In the same vein, EBS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.30, a figure that is expected to reach 0.27 in the next quarter, and analysts are predicting that it will be 1.75 at the market close of one year from today.
Technical Analysis of Emergent Biosolutions Inc (EBS)
Now, what If we examine the latest scores posted by [Emergent Biosolutions Inc, EBS]. During the last 5-days, its volume was better the volume of 1.21 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 55.23% While, its Average True Range was 83.08.
Raw Stochastic average of Emergent Biosolutions Inc (EBS) in the period of the previous 100 days is set at 92.69%, which indicates a major rise in contrast to 87.16% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.58 that was higher than 0.45 volatility it exhibited in the past 100-days period.
